A Randomized, Phase 2 Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 04 May 2016
At a glance
- Drugs Seribantumab (Primary) ; Paclitaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Merrimack Pharmaceuticals
- 10 Jun 2017 Biomarkers information updated
- 11 Mar 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Dec 2014 Results published in a Merrimack Pharmaceuticals media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History